Cargando…
Abnormal Liver Function Test in Patients Infected with Coronavirus (SARS-CoV-2): A Retrospective Single-Center Study from Spain
The outbreak of the novel coronavirus SARS-CoV-2 epidemic has rapidly spread and still poses a serious threat to healthcare systems worldwide. In the present study, electronic medical records containing clinical indicators related to liver injury in 799 COVID-19-confirmed patients admitted to a hosp...
Autores principales: | Benedé-Ubieto, Raquel, Estévez-Vázquez, Olga, Flores-Perojo, Vicente, Macías-Rodríguez, Ricardo U., Ruiz-Margáin, Astrid, Martínez-Naves, Eduardo, Regueiro, José R., Ávila, Matías A., Trautwein, Christian, Bañares, Rafael, Bosch, Jaume, Cubero, Francisco Javier, Nevzorova, Yulia A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959465/ https://www.ncbi.nlm.nih.gov/pubmed/33802486 http://dx.doi.org/10.3390/jcm10051039 |
Ejemplares similares
-
Guidelines and Considerations for Metabolic Tolerance Tests in Mice
por: Benedé-Ubieto, Raquel, et al.
Publicado: (2020) -
Fat: Quality, or Quantity? What Matters Most for the Progression of Metabolic Associated Fatty Liver Disease (MAFLD)
por: Estévez-Vázquez, Olga, et al.
Publicado: (2021) -
Alcohol and Hepatocellular Carcinoma: Adding Fuel to the Flame
por: Ramadori, Pierluigi, et al.
Publicado: (2017) -
Reclassifying Hepatic Cell Death during Liver Damage: Ferroptosis—A Novel Form of Non-Apoptotic Cell Death?
por: Macías-Rodríguez, Ricardo U., et al.
Publicado: (2020) -
A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy
por: Guo, Feifei, et al.
Publicado: (2021)